Literature DB >> 10931006

Complication of rapidly progressive glomerulonephritis in severe congenital neutropenia treated with long-term granulocyte colony-stimulating factor (filgrastim).

M Sotomatsu, T Kanazawa, C Ogawa, T Watanabe, A Morikawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10931006     DOI： 10.1046/j.1365-2141.2000.02072-1.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Acute glomerulonephritis in a donor as a side effect of allogeneic peripheral blood stem cell mobilization with granulocyte colony-stimulating factor.

Authors:  B Nasilowska-Adamska; A Perkowska-Ptasinska; A Tomaszewska; A Serwacka; B Marianska
Journal:  Int J Hematol       Date:  2010-12-01       Impact factor: 2.490

2.  Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropenia.

Authors:  Ofer Yanay; David C Dale; William R A Osborne
Journal:  Hum Gene Ther       Date:  2012-09-12       Impact factor: 5.695

3.  Filgrastim-Induced Crescentic Transformation of Recurrent IgG2λ GN.

Authors:  Ibrahim Batal; Glen S Markowitz; Waichi Wong; Rupali Avasare; Markus Y Mapara; Gerald B Appel; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2016-05-04       Impact factor: 10.121

4.  Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial.

Authors:  Safa Najafi; Maryam Ansari; Vahid Kaveh; Shahpar Haghighat
Journal:  BMC Cancer       Date:  2021-04-23       Impact factor: 4.430

5.  Relapsing acute kidney injury associated with pegfilgrastim.

Authors:  Swati Arora; Arpit Bhargava; Katherine Jasnosz; Barbara Clark
Journal:  Case Rep Nephrol Urol       Date:  2012-11-21

6.  Development of membranoproliferative glomerulonephritis-like glomerulopathy in a patient with neutrophilia resulting from endogenous granulocyte-colony stimulating factor overproduction: a case report.

Authors:  Seigo Ito; Takahiro Uchida; Naoki Oshima; Takashi Oda; Hiroo Kumagai
Journal:  BMC Nephrol       Date:  2018-10-04       Impact factor: 2.388
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.